维普中文期刊产品整合服务
3685篇 您的检索式:作者名="ITO A"
    题名 作者 年代 出处 被引量
1青藏高原东部地区发现的新种:石渠棘球绦虫的生物学特征显示文摘青藏高原东部是细粒棘球绦虫和多房棘球绦虫的混合流行区,诸多的家畜和野生动物参与了棘球绦虫的传播。近年来,一种未知的棘球绦虫先后从高原鼠兔(Ochotona curzoniae)和藏狐(Vulpes ferrilata)中被分离出来。由于其特有的形态学、分子遗传学、寄生宿主和地理分布特征,而被作为新种——石渠棘球绦虫(Echinococcus shiquicus,Xiaoetal,2005)进行了系统研究。本文对该虫种的生物遗传学和流行病学特征进行了讨论,并提出了理论上的假设来解释一些仍不十分清楚的现象。肖宁 邱加闽 Nakao M 李调英 陈兴旺 Schantz PM Craig PS Ito A 2008中国寄生虫学与寄生虫病杂志2008,26,4:29
2青海省达日县棘球蚴病流行病学调查显示文摘目的分析青海省果洛藏族自治州达日县棘球蚴病的流行分布现状,为制定预防控制措施提供科学依据。方法于2007年8~9月对达日县6个乡各2~3个自然村的3周岁以上常驻牧民分别用B超、间接红细胞凝集试验(IHA)和间接ELISA法(重组AgB和Em18抗原)检查两型棘球蚴病患病和感染情况。并调查当地啮齿类动物、牦牛、绵羊和野犬的感染情况,对采集的棘球绦虫和棘球蚴用PCR-RFLP方法进行虫种鉴定,并确定其基因型。收集牧民的家犬粪便,用双抗体夹心法检测粪抗原阳性率。结果共调查牧民1723人,B超查出棘球蚴病患者236例(占13.7%),其中囊型和泡型棘球蚴病患病率分别为5.5%(95/1723)和8.2%(141/1723)。男、女性棘球蚴病患病率分别为11.6%和16.0%(χ2=7.0,P<0.05)。家犬粪抗原阳性率为11.3%(31/275)。剖检9只无主犬,其中5只棘球绦虫感染阳性,对检获的虫体经PCR-RFLP鉴定,1只犬感染细粒棘球绦虫,基因型为G1,4只犬感染多房棘球绦虫。牦牛、绵羊的细粒棘球蚴感染率分别为26.4%(14/53)和5/16,对从牦牛、绵羊检获的细粒棘球蚴经PCR-RFLP鉴定,基因型均为G1。捕获高原鼠兔239只,石渠棘球绦虫感染率为11.3%(27/239)。结论达日县存在细粒棘球绦虫、多房棘球绦虫和石渠棘球绦虫的分布,泡型和囊型棘球蚴病在人群中严重流行,犬是细粒棘球绦虫和多房棘球绦虫主要传染源。韩秀敏 王虎 蔡辉霞 马霄 刘玉芳 韦炳辉 Ito A Craig PS 2009中国寄生虫学与寄生虫病杂志2009,27,1:30
3Int J Cardiol:非高密度脂蛋白胆固醇与冠心病的死亡率相关显示文摘非高密度脂蛋白(HDL)的胆固醇水平,一般不受空腹状态或血清甘油三酯水平的影响,可能有助于预测未来的心血管事件。2016年6月15日的《International Journal of Cardiology》刊载了一项研究,旨在探讨一般日本人群中,非高密度脂蛋白胆固醇在致命性冠状动脉事件和卒中的发展中的作用。Ito T Arima H Fujiyoshi A 2016疾病监测2016,31,7:6
4Preparation of Laminin-apatite-polymer Composites Using Metastable Calcium Phosphate Solutions显示文摘A synthetic polymer with a laminin-apatite composite layer on its surface would be useful as a percutaneous device. The preparation of such a composite was attempted in the present study using poly(ethylene terephthalate) (PET) and polyethylene (PE) as the synthetic polymer. PET and PE plates and those pretreated with an oxygen plasma were alternately dipped in calcium and phosphate ion solutions, and then immersed in a metastable calcium phosphate solution supplemented with laminin (LCP solution). The PET and PE plates pretreated with an oxygen plasma formed a uniform and continuous layer of a laminin-apatite composite on their surfaces. In contrast, the PET and PE plates that had not been pretreated with an oxygen plasma did not form a continuous layer of a laminin-apatite composite on their surfaces. The hydrophilic functional groups on the PET and PE surfaces introduced by the plasma treatment were responsible for the successful laminin-apatite composite coating.A Oyane M Kasahara N Ichinose Y Yokoyama M Uchida A Ito 2005Journal of Wuhan University of Technology(Materials Science)2005,20,B12:3
5SLC26A4 mutation testing for hearing loss associated with enlargement of the vestibular aqueduct显示文摘Pendred syndrome(PS) is characterized by autosomal recessive inheritance of goiter associated with a defect of iodide organification, hearing loss, enlargement of the vestibular aqueduct(EVA), and mutations of the SLC26A4 gene. However, not all EVA patients have PSor SLC26A4 mutations. Two mutant alleles of SLC26A4 are detected in 1/4 of North American or European EVA populations, one mutant allele is detected in another 1/4 of patient populations, and no mutations are detected in the other 1/2. The presence of two mutant alleles of SLC26A4 is associated with abnormal iodide organification, increased thyroid gland volume, increased severity of hearing loss, and bilateral EVA. The presence of a single mutant allele of SLC26A4 is associated with normal iodide organification, normal thyroid gland volume, less severe hearing loss and either bilateral or unilateral EVA. When other underlying correlations are accounted for, the presence of a cochlear malformation or the size of EVA does not have an effect on hearing thresholds. This is consistent with observations of an Slc26a4 mutant mouse model of EVA in which hearing loss is independent of endolymphatic hydrops or inner ear malformations. Segregation analyses of EVA in families suggest that the patients carrying one mutant allele of SLC26A4 have a second, undetected mutant allele of SLC26A4, and the probability of a sibling having EVA is consistent with its segregation as an autosomal recessive trait. Patients without any mutations are an etiologically heterogeneous group in which siblings have a lower probability of having EVA. SLC26A4 mutation testing can provide prognostic information to guide clinical surveillance and management, as well as the probability of EVA affecting a sibling.Taku Ito Julie Muskett Parna Chattaraj Byung Yoon Choi Kyu Yup Lee Christopher K Zalewski Kelly A King Xiangming Li Philine Wangemann Thomas Shawker Carmen C Brewer Seth L Alper Andrew J Griffith 2013World Journal of Otorhinolaryngology2013,3,2:2
6卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景 缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 2017国际脑血管病杂志2017,25,5:2
7胆固醇酯转移蛋白基因的蛋白质截断型变异体与冠状动脉性心脏病风险的关系显示文摘随机对照试验结果表明,抑制胆固醇酯转运蛋白(cholesteryl ester transfer protein,CETP)的疗法并不能降低冠状动脉性心脏病(coronary heart disease,CHD)的发生风险。研究失败的可能原因包括靶目标无效、靶目标外小分子的不良反应和随机对照设计因素影响等。在编码药物靶点的基因中具有天然存在的遗传变异,以此为基础,人类研究可以深入了解针对基因产物的治疗的潜在功效和安全性。Nomura A Won HH Khera AV Takeuchi F Ito K McCarthy S Emdin CA Klarin D Natarajan P Zekavat SM Gupta N Peloso GM Borecki IB Teslovich TM Asselta R Duga S Merlini PA Correa A Kessler T Wilson JG Bown MJ Hall AS Braund PS Carey DJ Murray MF Kirchner HL Leader JB Lavage DR Manus JN Hartze DN Samani NJ Schunkert H Marrugat J Elosua R McPherson R Farrall M Watkins H Juang JJ Hsiung CA Lin SY Wang JS Tada H Kawashiri MA Inazu A Yamagishi M Katsuya T Nakashima E Nakatochi M Yamamoto K Yokota M Momozawa Y Rotter JI Lander ES Rader DJ Danesh J Ardissino D Gabriel S Willer CJ Abecasis GR Saleheen D Kubo M Kato N Ida Chen YD Dewey FE Kathiresan S 刘莉 叶鹏 2017中华高血压杂志2017,25,9:2
8Novel antigens for neurocysticercosis: simple method for preparation and evaluation for sodiagnosis 显示文摘Ito A Plancarte A Ma L 1998Am J Trop Hyg1998,59,:2
9Continued circulation of reassortment H1N2 influenza viruses in pigs in Japan 显示文摘Ito T KawaokaY Vines A 1998Arch Virol1998,143,:1
10Feasibility of mieroneedles for percutaneous absorption of insulin显示文摘Ito Y Hagiwara E Saeki A 2006European journal of pharmaceutical sciences2006,29,1:1
11Local administration of methotrexate bound to activated carbon particles for treating cancers in mice 显示文摘Ito T Hagiwara A Takagi T 2003Anticancer Res2003,23,2:1
12survivin initiates procaspase 3/ P21 complex formation as a result of interaction with Cdk4 to resist Fas mediated cell death 显示文摘Suzuki A Ito T Kawano H 2000Oncogene2000,19,3:1
13Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells显示文摘Ito K Hirao A Arai F 2006Nat Med2006,12,:1
14Cysticercosis/taeniasis in Asia and the Pacific显示文摘Ito A Wandra T Yamasaki H 2004Vector Borne Zoonot Dis2004,4,2:1
15Em18 and Em16, new serologic marker epitopes for alveolar echinococcosis in western blot analysis, are the only two epitopes recognized by commercially available weak positive (cut off)sera for Em2plus-ELISA显示文摘 Osawa Y Nakao M 1995J Helminth1995,69,4:1
16The mitochondrial genome of the tapeworm Taenia solium:a finding of the abbreviated stop codon U显示文摘Nakao M Sako Y Ito A 2003J Parasitol2003,89,3:1
17Continuous arterial infusion of protease inhibitor with supplementary therapy for the patients Withsevere acute pan - creat it is Clinical effect of arterial injection of ulinastin 显示文摘Matsukawa H Hara A Ito T 1998Nippon Shokakib - yo Gakkai Zasshi1998,95,:1
18Introduction of on going research projects on echinococcosis at asahikawa medical college and some comments on the sur- veillance, prevention and control of alveolar echinococcosis in Japan 显示文摘Ito A 2001Hokkaido Igaku Zasshi2001,76,1:1
19Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type Ⅲ phosphodiesterase inhibitor in the CNS显示文摘Suzumura A Ito A Yoshikawa M 1999Brain Res1999,837,12:1
20Risk factors for the development of retinopathy in elderly Japanese patients with diabetes mellitus显示文摘ARAKI A ITO H HATTORI A 1993Diabetes Care1993,16,:1
返回顶部 每页显示:
共185页 首页 上一页 第1页 下一页 末页 /185 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费